Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria  by Tozawa, Masahiko et al.
Kidney International, Vol. 62 (2002), pp. 1743–1749
Triglyceride, but not total cholesterol or low-density
lipoprotein cholesterol levels, predict
development of proteinuria
MASAHIKO TOZAWA, KUNITOSHI ISEKI, CHIHO ISEKI, SAORI OSHIRO, YOSHIHARU IKEMIYA,
and SHUICHI TAKISHITA
Third Department of Internal Medicine and Dialysis Unit, University of The Ryukyus, and Okinawa General Health
Maintenance Association, Okinawa, Japan
Triglyceride, but not total cholesterol or low-density lipopro- Triglyceride rich lipoproteins such as very low-density
tein cholesterol levels, predict development of proteinuria. lipoprotein (VLDL) and intermediate-density lipopro-
Background. Epidemiological data about the relationship tein (IDL) can cause glomerulosclerosis [1] and promote
between dyslipidemia and proteinuria are sparse. We conducted
the proliferation of mesangial cells [2]. In a previousa retrospective and longitudinal study in a large screened cohort
study, hypertriglyceridemia was a borderline significantto evaluate whether triglyceride, high-density lipoprotein (HDL)
risk factor for progression of renal disease in chroniccholesterol, total cholesterol, and low-density lipoprotein (LDL)
cholesterol levels increase the risk of development of protein- renal failure [3], and in another study, its presence was
uria and loss of renal function. significantly more common at the time of renal biopsy
Methods. Post hoc analysis was performed for 4326 subjects in patients with progressive IgA nephropathy than in
who were free from proteinuria (dipstick 1 or higher) at base-
those with stable disease [4]. Increased concentration ofline (1997) with a follow-up period through 2000. Outcome mea-
triglyceride-rich, but not cholesterol rich, apolipoproteinsures were the development of proteinuria (1 or higher) and
change in glomerular filtration rate (GFR). Multiple logistic B (apoB)-containing lipoproteins was shown to be asso-
analysis and multiple regression analysis were used to analyze ciated with a rapid loss of renal function [5]. High triglyc-
baseline characteristics related to the outcome measures. eride and low high-density lipoprotein (HDL) choles-
Results. During the observational period, 505 (11.7%) of sub- terol levels were significant predictors of a rise in a serumjects had one or more episodes of proteinuria (1). Adjusted
creatinine [6]. All these previous studies examined therelative risk of triglycerides for one or more incidences of
relationship between lipids and kidney survival [3] usingproteinuria was 1.007 (95% CI 1.000 to 1.105, P  0.04) in
men and 1.032 (95% CI 1.004 to 1.061, P  0.02) in women. serum creatinine [4] or glomerular filtration rate (GFR)
Total cholesterol, HDL cholesterol, and LDL cholesterol were [5] as the index of renal function. Epidemiological data
not significant predictors of proteinuria. The mean change in on the relationship between lipids and proteinuria needs
GFR between 1997 and 2000 was 6.3 (SD  9.0) mL/min/ to be collected from a large cohort.1.73 m2 in men, and 7.8 (SD  10.7) mL/min/1.73 m2 in
In the present study, we evaluated whether triglycer-women. HDL cholesterol (  0.04, t  3.7, P  0.0002) in
ide, total cholesterol, HDL, and low-density lipoproteinmen and triglycerides (per 10 mg/dL,   0.09, t  2.2,
P  0.02) in women were correlated with the change in GFR. (LDL) cholesterol levels increase the risk of develop-
Conclusions. High triglyceride levels predicted a risk of de- ment of proteinuria or loss of renal function. Since hyper-
veloping proteinuria in both men and women, but not total tension [7] and diabetes mellitus [8] are established risk
cholesterol nor LDL cholesterol. High triglyceride in women factors for renal injury, we used multiple logistic analysisand low HDL cholesterol in men predicted the decline of renal
or multiple regression analysis to adjust for these factors.function. It remains to be determined whether prospective
treatment of dyslipidemia will protect against renal injury.
METHODS
Subjects in our current study were participants in aKey words: HDL cholesterol, LDL cholesterol, dyslipidemia, renal func-
tion, glomerulosclerosis, Okinawa renal study, progressive renal injury. screening program that has been reported previously
[9, 10]. The screening, run by the Okinawa General
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women (31%)] participated in the program four years
 (age)0.176
in a row (1997 through 2000) by mere chance. Among
 (0.762 if the patient is female)these 4612 subjects, 286 subjects who had dipstick posi-
tive proteinuria (1) in 1997 were excluded. In the
 (1.180 if patient is black)
present study, post hoc analyses were done in the 4326
 (serum urea nitrogen)0.170subjects [2967 men (69%), 1359 women (31%)] who were
free from proteinuria at baseline (1997). The present  (serum albumin)0.318 (Eq. 1)
study was conducted in accordance with the principles
Individual slope of GFR from 1997 through 2000 wasset out in the Declaration of Helsinki 1975, as revised
calculated using all four points of measurement (1997,in 1993. The study design was approved by the ethical
1998, 1999 and 2000). From that slope, the individualcommittee of the Association. Only the field data set,
change in GFR for the whole period (from 1997 to 2000)which excluded the private information such as name
was calculated.and address, was used for this study. All participants
were informed of the nature of the screening and all
Statistical methodssigned for the questionnaire.
The unpaired t test or chi-squared test was used toThe subject’s past and current medical history was
analyze differences in values or ratios between groups.recorded on a self-administered, standardized question-
The chi squared (2) test for trend [14] and analysis ofnaire. To corroborate the collected information, a physi-
variance (ANOVA) was used to test the linearity acrosscian also interviewed every subject. Dipstick urinalysis
quintiles. Relative risk of developing proteinuria was(Ames dipstick) was performed on fresh, mid-stream urine
estimated by using multiple logistic regression modelscollected in the morning. The results of the urine test were
(StatView 5.0; SAS Institute, Cary, NC, USA). Adjust-interpreted as: (), (/), (1), (2), (3) or (4).
ments were made for age, sex, and baseline body massHeight, body weight, blood pressure, blood hemoglobin
index (BMI), serum creatinine, systolic blood pressure(Hb), fasting blood glucose, Hb A1c, serum urea nitrogen
(SBP), diabetes mellitus, antihypertensive medication use,(SUN), serum creatinine, serum albumin, triglycerides,
and current cigarette smoking (yes/no). To analyze thetotal cholesterol, triglyceride, and HDL cholesterol were
correlated factors with the change in GFR, multiple re-measured in all subjects. All the subjects fasted overnight
gression analysis was performed. In the equation, changebefore blood sampling. Serum creatinine was measured by
in GFR was considered the dependent factor, while age,the enzyme-based method. After the subjects sat for 15
sex, and baseline BMI, serum creatinine, SBP, diabetesminutes, blood pressure was measured twice by a trained
mellitus, and antihypertensive medication use were con-
nurse using a standard sphygmomanometer. The lower
sidered independent factors. P  0.05 was considered
value of two blood pressure measurements was used for significant.
this study. Diabetes mellitus was diagnosed if the fasting
blood glucose level was 126 mg/dL (7 mmol/L) [11],
RESULTSHb A1c was 	7.0%, or the subject was under diabetes
mellitus therapy. LDL cholesterol was calculated from Descriptive statistics
the formula: LDL cholesterol total cholesterolHDL Baseline characteristics are present in Table 1. BMI,
cholesterol  triglycerides/5 [12]. percentage of diabetes mellitus and smoking, blood Hb,
Hb A1c, serum albumin, serum urea nitrogen, serum cre-Definition of outcome measures
atinine, GFR, SBP and diastolic blood pressure (DBP),
Proteinuria. A urine test result of (1) or greater was and triglyceride levels were higher (P  0.05) in men
considered positive for proteinuria and test results of than in women. Total cholesterol, HDL cholesterol, and
() or (/) were considered negative for proteinuria. LDL cholesterol levels were higher (P 0.05) in women
All subjects enrolled in this study were free from protein- than men. Percentages of the medical treatment of hy-
uria at the baseline measurement in 1997. Development pertension and hyperlipidemia were not significantly dif-
of proteinuria defined as positive if 1 or greater pro- ferent between men and women in 1997. The incidence
teinuria was present from 1998 through 2000. Therefore, of 1 higher proteinuria in men was 4.6% in 1998, 6.5%
the maximum frequency was thrice. in 1999, and 6.4% in 2000; in women it was 3.2% in 1998,
Change in GFR. GFR (mL/min/1.73 m2) was estimated 4.5% in 1999, and 4.3% in 2000.
from a formula by the Modification of Diet in Renal
Relationship of the lipid profile to incidence ofDisease study (MDRD) [13]:
proteinuria and change in GFR
GFR (mL/min/1.73 m2)  170
Univariate analysis. Triglyceride quintiles had a posi-
tive and linear relation to the incidence of one or more (serum creatinine)0.999
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Table 1. Baseline characteristics of the study subjects
Men Women
N  2967 N  1359
Age years 47
9 50
9
Body mass index kg/m2 24.4
2.8 23.3
3.1
Diabetes mellitus 6.0% 3.0%
Current smoking (yes) 41.6% 4.5%
Blood Hb g/dL 15.4
1.0 13.1
1.3
Hb A1c % 4.93
0.63 4.87
0.51
Serum albumin g/dL 4.5
0.2 4.4
0.2
Serum urea nitrogen mg/dL 15.1
3.5 14.1
3.5
Serum creatinine mg/dL 1.1
0.1 0.8
0.1
GFR mL/min/1.73 m2 83
12 82
14
SBP mm Hg 122
16 119
17
DBP mm Hg 77
11 72
10
Antihypertensive medication use 7.2% 7.8%
Total cholesterol mg/dL 205
34 210
37
Triglycerides mg/dL 166
129 104
61
HDL cholesterol mg/dL 52
13 62
14
LDL cholesterol mg/dL 120
33 127
33
Medical treatment for hyperlipidemia 0.7% 0.7%
Values are expressed mean 
 SD or percentage. Abbreviations are: Hb, hemo-
globin, HDL, high-density lipoprotein; LDL, low-density lipoprotein; GFR, glo-
merular filtration rate; SBP, systolic blood pressure; DBP, diastolic blood pres-
sure.
episodes of proteinuria in men (P  0.002, Fig. 1A),
but not in women (P  0.06). The quintiles of HDL
cholesterol had a negative and linear relationship to the
incidence of proteinuria in men (P  0.02, Fig. 1B), but Fig. 1. Quintiles of triglycerides and HDL cholesterol related to the
incidence of once or more episodes of proteinuria ( men;  women)not in women (P  0.84). Total cholesterol and LDL
and change in glomerular filtration rate (GFR;  men;  women). Pcholesterol levels had no significant association with the values are given by a test for linearity across quintiles (chi-squared test
incidence of proteinuria (Fig. 2, A, B). The relationship for trend of proteinuria incidence and ANOVA for change in GFR).
(A) P  0.002 for men and P  0.06 for women. (B) P  0.02 for menbetween lipid quintiles and changes in GFR was not
and P  0.84 for women. (C ) P  0.47 for men and P  0.53 forsignificant (Fig. 1 C, D; and Fig. 2 C, D). women. (D) P  0.11 for men and P  0.22 for women. The number
Multivariate analysis. The results of multiple logistic of persons per quintile are: (A and C) 590 to 597 men and 261 to 271
women; (panel B and D) 577 to 612 men and 258 to 289 women.analyses of baseline characteristics related to the devel-
opment of proteinuria are shown in Table 2. Triglyceride
levels were significant predictors of one or more episodes
of proteinuria in either men (P  0.04) or women (P  stolic blood pressure (DBP) quintiles had a positive and
0.02). Triglycerides were significant predictors of three linear relationship to the incidence of proteinuria in men
episodes of proteinuria in women (P 0.03). The results (P  0.0001; Fig. 3B), but not in women (P  0.24).
of multiple regression analysis of baseline characteristics The relationship between the BP quintiles and change
related to the change in GFR from 1997 through 2000 in GFR were not significant (Fig. 3 C, D).
are shown in Table 3. In women, triglycerides had a neg- Multivariate analysis. Multiple logistic analyses showed
ative association with change in GFR (P  0.02) while that SBP in both men and women, and DBP, BMI, diabe-
men showed that HDL cholesterol had a positive rela- tes mellitus, and smoking in men were significant pre-
tionship to change in GFR (P  0.0002). Triglyceride in dictors of the development of one or more incidence of
men, LDL cholesterol in women, and total cholesterol proteinuria. Adjusted relative risk (RR) for each study
and LDL cholesterol in both men and women had no parameter was: SBP (10 mm Hg) RR  1.188 (CI 
significant relationship to change in GFR. 1.100 to 1.282, P  0.0001) for men and RR  1.145
(CI  1.014 to 1.292, P  0.02) for women; DBP (10
Relationships of other risk factors to incidence of mm Hg), RR  1.259 (CI  1.125 to 1.408, P  0.0001)
proteinuria and change in GFR for men and RR  1.216 (CI  0.999 to 1.481, P  0.05)
Univariate analysis. Systolic blood pressure (SBP) for women; BMI (kg/m2), RR  1.089 (CI  1.047 to
quintiles had a positive and linear relationship to the 1.132, P  0.001) for men and RR  1.014 (CI  0.952
incidence of one or more episodes of proteinuria in men to 1.080, P  0.66) for women; diabetes mellitus (yes 
1, no  0), RR  1.795 (CI  1.227 to 2.625, P  0.002)(P 0.0001, Fig. 3A) but not in women (P  0.20). Dia-
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lesterol in men also correlated with a decrease in GFR.
To our knowledge this is the first large epidemiological
study in which triglyceride, but not cholesterol, was shown
to be a risk factor for the development of proteinuria.
Samuelsson et al showed that triglyceride-rich, but not
cholesterol-rich, apolipoprotein B-containing lipopro-
teins are associated with a rapid loss of renal function
in chronic renal insufficiency [5]. Syrja¨nen, Mustonen
and Pasternack reported that hypertriglyceridemia was
a significant predictor of poor outcome in patients with
IgA nephropathy [4]. In a prospective study of 12,728
subjects, high triglycerides and low HDL cholesterol, but
not LDL cholesterol, were shown to predict a risk of in-
crease in serum creatinine [6]. Our previous study found
that, when adjusted for urinalysis and blood pressure,
serum cholesterol was not a significant risk factor for
end-stage renal disease in a cohort from mass screening
[15]. Our present results are comparable with these pre-
vious results, and provide new epidemiological evidence
for the relationship between lipid profile and renal injury.
Our subjects participated in a screening program
where most often it was the individual participants who
paid the examination fee and subjects were mainly em-
ployees of local companies. This may be one reason why
the number of men was larger than that of women. As
an index of renal function, we chose GFR calculated by
the MDRD formula, which is more accurate in predictingFig. 2. Quintiles of total cholesterol and LDL cholesterol related to
the incidence of one or more episodes of proteinuria (men;women) GFR than measuring creatinine clearance or other com-
and change in glomerular filtration rate (GFR;  men;  women). P monly used equations [13]. In our study, the duration of
values are given by a test for linearity across quintiles (chi-squared test
observation was relatively short and the change in GFRfor trend of proteinuria incidence and ANOVA for change in GFR).
(A) P  0.41 for men and P  0.99 for women; (B) P  0.96 for men small. This may be why no significant relationship be-
and P  0.99 for women; (C ) P  0.15 for men and P  0.11 for tween lipids and change in GFR was observed in the
women; (D) P  0.09 for men and P  0.50 for women. The number
univariate analysis (Figs. 1 and 2). In univariate analysis,of persons per quintile are: (A and C) 579 to 611 men and 264 to 278
women; (B and D) 591 to 595 men and 270 to 273 women. HDL cholesterol was associated with the incidence of pro-
teinuria in men (Fig. 1B); however, after adjusting for age,
body mass index, serum creatinine, systolic blood pres-
sure, diabetes mellitus, antihypertensive medication usefor men and RR  0.730 (CI  0.247 to 2.156, P  0.56)
and current smoking habit, the significant relationshipfor women; current smoker (yes  1, no  0), RR 
between HDL cholesterol and the development of pro-1.316 (CI  1.043 to 1.669, P  0.02) for men and RR 
teinuria was lost (Table 2). The results show that the0.865 (CI  0.334 to 2.243, P  0.76) for women. The
adjusted variables are confounding factors in the analy-multiple regression analysis showed that SBP and DBP
sis, and the strength of association between HDL choles-did not have a significant relationship to the change in
terol and proteinuria was not significant. We also calcu-GFR. Parameters were: SBP (10 mm Hg),   0.14,
lated all results after excluding the subjects with medicalt  1.4, P  0.15 for men and   0.20, t  1.2,
treatment for hyperlipidemia (data not shown). The num-P  0.21 for women; DBP (10 mm Hg),   0.22, t 
ber of subjects under medical treatment was so small1.5, P  0.12 for men and   0.21, t  0.83, P 
(Table 1) that the results of the present study were not0.40 for women.
influenced by this factor.
Moorhead et al hypothesized that initial glomerular
DISCUSSION injury induces dyslipidemia and progressive renal injury
[16]. In the present study, the baseline triglyceride mea-The major finding of the present study was that in a
large screened cohort triglycerides were an independent surements predicted the development of proteinuria in
the following three years. However, we had no informa-risk factor for the development proteinuria in men and
women, whereas total cholesterol and LDL cholesterol tion concerning the presence of proteinuria in our sub-
jects before the study began and, therefore, we cannotwere not. High triglyceride in women and low HDL cho-
Tozawa et al: Triglyceride and proteinuria 1747
Table 2. Results of multiple logistic analysis of baseline characteristics related to the development of proteinuria
Development of proteinuria
Once or more Thrice
N  505 N  42
(men 377/women 128) (men 35/women 7)
Parameter Adjusted RRa (95% CI) P Adjusted RRa (95% CI) P
Men (N  2967)
Total cholesterol 10 mg/dL 1.016 (0.985–1.049) 0.31 1.055 (0.962–1.156) 0.25
Triglycerides 10 mg/dL 1.007 (1.000–1.105) 0.04 1.004 (0.980–1.028) 0.76
HDL cholesterol 1 mg/dL 0.992 (0.983–1.002) 0.10 0.995 (0.967–1.023) 0.70
LDL cholesterol 10 mg/dL 1.000 (0.968–1.034) 0.99 1.055 (0.957–1.163) 0.28
Women (N  1359)
Total cholesterol 10 mg/dL 1.008 (0.953–1.065) 0.78 1.060 (0.866–1.297) 0.57
Triglycerides 10 mg/dL 1.032 (1.004–1.061) 0.02 1.091 (1.006–1.184) 0.03
HDL cholesterol 1 mg/dL 0.994 (0.980–1.008) 0.36 0.990 (0.935–1.048) 0.72
LDL cholesterol 10 mg/dL 0.995 (0.935–1.058) 0.86 0.997 (0.775–1.284) 0.98
Abbreviations are: HDL, high-density lipoprotein; LDL, low-density lipoprotein; RR, relative risk.
a Adjusted for age, and baseline body mass index, serum creatinine, systolic blood pressure, diabetes mellitus, antihypertensive medication use and current cigarette
smoking
Table 3. Results of multiple regression analysisa of baseline
characteristics related to the change in GFR
Parameter  t P
Men (N  2967)
Total cholesterol 10 mg/dL 0.04 0.9 0.32
Triglycerides 10 mg/dL 0.01 0.9 0.32
HDL cholesterol 1 mg/dL 0.04 3.7 0.0002
LDL cholesterol 10 mg/dL 0.01 0.3 0.7
Women (N  1359)
Total cholesterol 10 mg/dL 0.79 1.1 0.26
Triglycerides 10 mg/dL 0.09 2.2 0.02
HDL cholesterol 1 mg/dL 0.17 0.9 0.34
LDL cholesterol 10 mg/dL 0.06 0.7 0.43
Abbreviations are: GFR, glomerular filtration rate, HDL, high-density lipo-
protein; LDL, low-density lipoprotein.
a Adjusted for age, and baseline body mass index, serum creatinine, systolic
blood pressure, diabetes mellitus, and antihypertensive medication use
rule out the possibility that previous renal injury induced
the dyslipidemia. In such cases, protein from glomeruli
might activate some signals through renal tubular epithe-
lium to increase triglyceride production [16]. These
mechanisms may explain the dyslipidemia found in ne-
phrotic syndrome [17, 18].
Recent evidence shows that dyslipidemia per se is a
risk factor for progressive renal disease [1–6]. Other re-
searchers reported that the development of focal segmen-
tal glomerular sclerosis was correlated with serum tri-
glyceride, but not serum cholesterol level in unilaterally
nephrectomized rats [19]. LDL and triglyceride-rich lipo-
proteins caused proliferation of human mesangial cells Fig. 3. Quintiles of systolic and diastolic blood pressure (BP) values
related to the incidence of one or more episodes of proteinuria (men;[2]. In the results of another study, triglyceride-rich apoB-
 women) and change in glomerular filtration rate (GFR;  men;containing lipoproteins clearly promoted the progression
 women). P values are given by a test for linearity across quintiles
of human renal insufficiency [5]. Although the mecha- (chi-squared test for trend of proteinuria incidence and ANOVA for
change in GFR). (A) P  0.0001 for men and P  0.20 for women.nisms whereby lipids contribute to renal injury are in-
(B) P  0.0001 for men and P  0.24 for women. (C) P  0.63 for mencompletely understood, some basic findings are known.
and P 0.64 for women. (D) P 0.52 for men and P 0.70 for women.
Oxidized lipoprotein, which may be oxidized by mesan- The number of persons per quintile are: (A and C) 458 to 681 men and
231 to 325 women; (B and D) 426 to 694 men and 168 to 339 women.gial cells, has been found in the glomeruli and interstitial
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regions [20]. Several cytokines may be involved in renal Prospective intervention trials to investigate the relation-
ship between lipids and renal injury appear warranted.injury. The secretions of interleukin-6, platelet-derived
growth factor, transforming growth factor-, and tumor
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